InvestorsHub Logo
Followers 18
Posts 6649
Boards Moderated 0
Alias Born 03/06/2010

Re: Pharma Sleuth post# 389680

Saturday, 10/21/2023 11:35:03 AM

Saturday, October 21, 2023 11:35:03 AM

Post# of 401568
Lol that’s what I thought. You simply stated to ignore R&D. In all acquisitions of which I have been a part, R&D has Never been ignored. Not once.

If there’s a benefit, it’s a synergy, but not excluded when taking into consideration from an acquisition or forward multiple standpoint.

Thanks for admitting you have zero experience in this space. Sit back down and pretend like you do from your computer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News